Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
It is not simple
Provider guidance is essential to set realistic expectations for your situation
Important limitations include: Most evidence derives from preclinical or observational studies No randomized controlled trials specifically evaluate tirzepatide for autoimmune disease Mechanisms remain incompletely understood Clinical translation of anti-inflammatory effects is uncertain There is currently no established clinical evidence that tirzepatide effectively treats autoimmune diseases
Management: Use cautiously, especially in patients with cardiovascular conditions
Sanjari M, Yarmohammadi H, Fahimfar N, et al
Whereas, semaglutides results are more impressive
